Comparative Pharmacology
Head-to-head clinical analysis: DYNA HEX 2 versus TERRAMYCIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DYNA HEX 2 versus TERRAMYCIN.
DYNA-HEX 2 vs TERRAMYCIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate is a cationic bisbiguanide antiseptic that disrupts microbial cell membranes by binding to negatively charged bacterial cell walls, causing leakage of intracellular contents and cell death. It has broad-spectrum activity against gram-positive and gram-negative bacteria, fungi, and some viruses.
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-tRNA from binding to the A site.
1-2 mg IV/IM every 4-6 hours as needed for anxiety, up to 10 mg/day.
250-500 mg orally every 6 hours or 1-2 g intravenously every 12 hours. Maximum oral dose: 2 g/day.
None Documented
None Documented
2-4 hours; prolonged in renal impairment (up to 10-12 hours in anuria).
Terminal elimination half-life: 8-10 hours in normal renal function; prolonged to 20-40 hours in severe renal impairment (creatinine clearance <10 mL/min).
Primarily renal (70-80% unchanged) with minor biliary excretion (<5%) and fecal elimination (<5%).
Renal (primarily glomerular filtration, 20-60% unchanged in urine), biliary/fecal (10-30% via bile into feces).
Category C
Category C
Tetracycline Antibiotic
Tetracycline Antibiotic